November 8, 2016 - It is with great pleasure to announce the selection of PhoenixMD for the Canadian Technology Accelerator (CTA) program in Silicon Valley, California. The CTA San Francisco program gives Canadian companies the opportunity to gain global recognition and insight into the competitive life science market. San Francisco/Silicon Valley is home to one of the largest life science hubs and markets in the U.S. which grants unparalleled access to global multi-nationals, investors and venture financers. PhoenixMD was selected among hundreds of Canadian companies to go to California to access the resources required to accelerate our growth in the U.S. and the world! PhoenixMD will have the opportunity to be introduced to the U.S./Global market, Fortune 500 companies, investors and strategic partners.
The acceptance into the CTA program will bring PhoenixMD one step close to finding a cure for cancer.